Get started
THERAVANCE BIOPHARMATHERAVANCE BIOPHARMATHERAVANCE BIOPHARMA

THERAVANCE BIOPHARMA

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

0TB chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪408.63 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.80EUR
Net income (FY)
‪−50.01 M‬EUR
Revenue (FY)
‪52.03 M‬EUR
Shares float
‪44.03 M‬
Beta (1Y)
0.38

About Theravance Biopharma, Inc.

Sector
Health Technology
CEO
Rick E. Winningham
Headquarters
South San
Website
theravance.com
Employees (FY)
99
Founded
2013
FIGI
BBG0076S6PF8
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange THERAVANCE BIOPHARMA stocks are traded under the ticker 0TB.
We've gathered analysts' opinions on THERAVANCE BIOPHARMA future price: according to them, 0TB price has a max estimate of 19.32 EUR and a min estimate of 9.20 EUR. Watch 0TB chart and read a more detailed THERAVANCE BIOPHARMA stock forecast: see what analysts think of THERAVANCE BIOPHARMA and suggest that you do with its stocks.
0TB reached its all-time high on May 10, 2017 with the price of 38.30 EUR, and its all-time low was 4.30 EUR and was reached on Sep 15, 2021. View more price dynamics on 0TB chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track THERAVANCE BIOPHARMA financials in yearly and quarterly reports right on TradingView.
THERAVANCE BIOPHARMA is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
0TB earnings for the last quarter are −0.22 EUR per share, whereas the estimation was −0.23 EUR resulting in a 4.95% surprise. The estimated earnings for the next quarter are −0.19 EUR per share. See more details about THERAVANCE BIOPHARMA earnings.
THERAVANCE BIOPHARMA revenue for the last quarter amounts to ‪13.44 M‬ EUR despite the estimated figure of ‪12.94 M‬ EUR. In the next quarter revenue is expected to reach ‪14.17 M‬ EUR.
0TB net income for the last quarter is ‪−10.81 M‬ EUR, while the quarter before that showed ‪−7.71 M‬ EUR of net income which accounts for −40.19% change. Track more THERAVANCE BIOPHARMA financial stats to get the full picture.
No, 0TB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 99.00 employees. See our rating of the largest employees — is THERAVANCE BIOPHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERAVANCE BIOPHARMA EBITDA is ‪−32.65 M‬ EUR, and current EBITDA margin is −82.27%. See more stats in THERAVANCE BIOPHARMA financial statements.
Like other stocks, 0TB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERAVANCE BIOPHARMA stock right from TradingView charts — choose your broker and connect to your account.